US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Actinium Pharmaceuticals

1.11

+0.07006.73%

Post-market: 1.110.00000.00%16:10 EST

Volume:75.17K

Turnover:80.58K

Market Cap:34.63M

PE:-1.00

High:1.12

Open:1.04

Low:1.04

Close:1.04

52wk High:2.41

52wk Low:1.02

Shares:31.20M

Float Shares:31.04M

Volume Ratio:0.58

T/O Rate:0.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1090

EPS(LYR):-1.2718

ROE:-133.09%

ROA:-33.76%

PB:2.51

PE(LYR):-0.87

Loading ...

Overview Company News Filings

Actinium Pharmaceuticals to Present ATNM-400 and Actimab-A Data at AACR 2026

Actinium Pharmaceuticals Inc - Steve O'loughlin Resigns as CFO - SEC Filing

THOMSON REUTERS

Actinium Pharmaceuticals CEO Sandesh Seth Named Chief Financial Officer

Actinium Pharmaceuticals Unveils Potent Preclinical Results for ATNM-400 Targeted Radiotherapy in Breast Cancer Models

BRIEF-ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS

Actinium Pharmaceuticals Unveils Preclinical Data Showing ATNM-400 Overcomes Breast Cancer Therapy Resistance

Actinium Pharmaceuticals Announces Atnm-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and Her2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium

THOMSON REUTERS

Actinium Pharmaceuticals Holds Annual Stockholders Meeting

Actinium Pharmaceuticals Inc. Held Annual Shareholder Meeting

Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating

Actinium Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholder Meeting

Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating

Actinium Pharmaceuticals Unveils Promising ATNM-400 Data for Drug-Resistant Breast Cancer at SABCS 2025

Actinium Pharmaceuticals to Join Stephens Biotechnology Virtual Fireside Chat

Actinium Pharmaceuticals: Promising Preclinical Success and Innovative Radiotherapy Developments Drive Buy Rating

Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity

Actinium Pharmaceuticals Reports Potent Preclinical Efficacy for Novel ATNM-400 Radiotherapy

Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals

Actinium Pharmaceuticals Unveils Preclinical Data Showing ATNM-400 Overcomes Osimertinib Resistance in EGFR-Mutated NSCLC at AACR-NCI-EORTC Conference

Actinium Pharmaceuticals Unveils Promising Preclinical Data for ATNM-400, Highlighting Durable Tumor Control in Resistant Prostate Cancer Models

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATNM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","market":"US","secType":"STK","nameCN":"Actinium Pharmaceuticals","latestPrice":1.11,"timestamp":1771534800000,"preClose":1.04,"halted":0,"volume":75172,"hourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.11,"latestTime":"16:10 EST","volume":342,"amount":379.62000000000006,"timestamp":1771535404798,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.06730769230769236,"floatShares":31037749,"shares":31195891,"eps":-1.109015,"marketStatus":"Post-Mkt","change":0.07,"latestTime":"02-19 17:28:08 EST","open":1.04,"high":1.12,"low":1.04,"amount":80579.7411,"amplitude":0.076923,"askPrice":1.14,"askSize":120,"bidPrice":0.9786,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.109015,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771549200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":1.04,"preHourTrading":{"tag":"盘前","latestPrice":1.04,"preClose":1.04,"latestTime":"09:20 EST","volume":620,"amount":644.694972,"timestamp":1771510835905,"change":0,"changeRate":0,"amplitude":0.009615},"postHourTrading":{"tag":"盘后","latestPrice":1.11,"preClose":1.11,"latestTime":"16:10 EST","volume":342,"amount":379.62000000000006,"timestamp":1771535404798,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.578198,"impliedVol":0.0009,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATNM\",,,,,undefined,":{"symbol":"ATNM","floatShares":31037749,"roa":"-33.76%","roe":"-133.09%","lyrEps":-1.271797,"volumeRatio":0.578198,"shares":31195891,"dividePrice":0,"high":1.12,"amplitude":0.076923,"preClose":1.04,"low":1.04,"week52Low":1.02,"pbRate":"2.51","psRate":"384.75","week52High":2.41,"institutionHeld":0,"latestPrice":1.11,"committee":-0.090909,"eps":-1.109015,"divideRate":0,"volume":75172,"delay":0,"ttmEps":-1.109015,"open":1.04,"prevYearClose":1.36,"prevWeekClose":1.11,"prevMonthClose":1.16,"prevQuarterClose":1.36,"fiveDayClose":1.12,"twentyDayClose":1.32,"sixtyDayClose":1.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"ATNM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-08","symbol":"ATNM","fiscalQuarterEnding":"2025/06","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2025-05-09","symbol":"ATNM","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2025-03-31","symbol":"ATNM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"ATNM","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATNM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1723438800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATNM","date":"2026-02-18","current":-0.955803,"percent":0.95114,"low":-13.279332,"twenty":-6.856789,"median":-4.808567,"eighty":-1.227564,"high":-0.808203,"avg":-4.426862,"sd":2.713508,"marketCap":33691562},"quantilePoints":[{"date":"2021-02-19","current":-5.856605,"twenty":-4.232345,"median":-2.782388,"eighty":-1.751477,"marketCap":119697285},{"date":"2021-02-26","current":-5.358029,"twenty":-4.260374,"median":-2.782388,"eighty":-1.751477,"marketCap":109507391},{"date":"2021-03-05","current":-5.151951,"twenty":-4.316431,"median":-2.782032,"eighty":-1.751353,"marketCap":105295568},{"date":"2021-03-12","current":-6.102569,"twenty":-4.34446,"median":-2.782032,"eighty":-1.751353,"marketCap":124724299},{"date":"2021-03-19","current":-5.889843,"twenty":-4.65353,"median":-2.782032,"eighty":-1.751353,"marketCap":120376611},{"date":"2021-03-26","current":-5.590697,"twenty":-5.123456,"median":-2.782388,"eighty":-1.751477,"marketCap":114262675},{"date":"2021-04-01","current":-6.982662,"twenty":-5.222416,"median":-2.782388,"eighty":-1.751477,"marketCap":155119842},{"date":"2021-04-09","current":-7.043306,"twenty":-5.251335,"median":-2.782032,"eighty":-1.751353,"marketCap":156467036},{"date":"2021-04-16","current":-6.462861,"twenty":-5.352711,"median":-2.782032,"eighty":-1.751353,"marketCap":143572459},{"date":"2021-04-23","current":-6.783405,"twenty":-5.381497,"median":-2.782032,"eighty":-1.751353,"marketCap":150693345},{"date":"2021-04-30","current":-6.636128,"twenty":-5.41615,"median":-2.782032,"eighty":-1.751353,"marketCap":147421587},{"date":"2021-05-07","current":-6.315584,"twenty":-5.475028,"median":-2.782032,"eighty":-1.751353,"marketCap":140300701},{"date":"2021-05-14","current":-6.548439,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":143181621},{"date":"2021-05-21","current":-7.425875,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162366746},{"date":"2021-05-28","current":-7.536708,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":164790131},{"date":"2021-06-04","current":-7.666015,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":167617412},{"date":"2021-06-11","current":-7.859974,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":171858335},{"date":"2021-06-18","current":-7.416638,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":162164798},{"date":"2021-06-25","current":-7.767613,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":169838848},{"date":"2021-07-02","current":-7.084137,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":154894645},{"date":"2021-07-09","current":-6.705454,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":146614748},{"date":"2021-07-16","current":-6.631565,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":144999159},{"date":"2021-07-23","current":-6.529967,"twenty":-5.488323,"median":-2.782032,"eighty":-1.751353,"marketCap":142777723},{"date":"2021-07-30","current":-6.381858,"twenty":-5.501619,"median":-2.782032,"eighty":-1.751353,"marketCap":142066551},{"date":"2021-08-06","current":-6.631,"twenty":-5.539494,"median":-2.782032,"eighty":-1.751353,"marketCap":147612692},{"date":"2021-08-13","current":-6.056058,"twenty":-5.590697,"median":-2.782032,"eighty":-1.751353,"marketCap":134813904},{"date":"2021-08-20","current":-5.778169,"twenty":-5.614629,"median":-2.782032,"eighty":-1.751353,"marketCap":128627823},{"date":"2021-08-27","current":-5.806916,"twenty":-5.640622,"median":-2.782032,"eighty":-1.751353,"marketCap":129267762},{"date":"2021-09-03","current":-6.084805,"twenty":-5.722321,"median":-2.782032,"eighty":-1.751353,"marketCap":135453843},{"date":"2021-09-10","current":-5.768587,"twenty":-5.785835,"median":-2.782032,"eighty":-1.751353,"marketCap":128414510},{"date":"2021-09-17","current":-7.502996,"twenty":-5.805755,"median":-2.782032,"eighty":-1.751353,"marketCap":167024188},{"date":"2021-09-24","current":-9.266152,"twenty":-5.825538,"median":-2.782032,"eighty":-1.751353,"marketCap":206273806},{"date":"2021-10-01","current":-8.221674,"twenty":-5.861923,"median":-2.782032,"eighty":-1.751353,"marketCap":183022674},{"date":"2021-10-08","current":-7.675478,"twenty":-5.872646,"median":-2.782388,"eighty":-1.751477,"marketCap":170863825},{"date":"2021-10-15","current":-7.704226,"twenty":-5.908489,"median":-2.782388,"eighty":-1.751477,"marketCap":171503764},{"date":"2021-10-22","current":-8.162229,"twenty":-5.955546,"median":-2.786754,"eighty":-1.751477,"marketCap":181699377},{"date":"2021-10-29","current":-7.766484,"twenty":-6.037658,"median":-2.799692,"eighty":-1.751477,"marketCap":172889710},{"date":"2021-11-05","current":-8.19191,"twenty":-6.083553,"median":-2.80245,"eighty":-1.751477,"marketCap":182360102},{"date":"2021-11-12","current":-7.586665,"twenty":-6.12087,"median":-2.817736,"eighty":-1.751477,"marketCap":175585778},{"date":"2021-11-19","current":-7.253499,"twenty":-6.156519,"median":-2.817736,"eighty":-1.751477,"marketCap":167874985},{"date":"2021-11-26","current":-6.939371,"twenty":-6.198706,"median":-2.820255,"eighty":-1.751477,"marketCap":160604809},{"date":"2021-12-03","current":-6.044583,"twenty":-6.219755,"median":-2.829029,"eighty":-1.751477,"marketCap":139895821},{"date":"2021-12-10","current":-6.520534,"twenty":-6.241046,"median":-2.833898,"eighty":-1.751477,"marketCap":150911240},{"date":"2021-12-17","current":-6.663319,"twenty":-6.265854,"median":-2.852054,"eighty":-1.751477,"marketCap":154215866},{"date":"2021-12-23","current":-6.339673,"twenty":-6.291084,"median":-2.855689,"eighty":-1.751477,"marketCap":146725381},{"date":"2021-12-31","current":-5.720936,"twenty":-6.291084,"median":-2.8711,"eighty":-1.751477,"marketCap":132405336},{"date":"2022-01-07","current":-5.854202,"twenty":-6.290587,"median":-2.879943,"eighty":-1.7516,"marketCap":135489653},{"date":"2022-01-14","current":-5.530555,"twenty":-6.290587,"median":-2.883827,"eighty":-1.7516,"marketCap":127999168},{"date":"2022-01-21","current":-5.09268,"twenty":-6.290587,"median":-2.913684,"eighty":-1.7516,"marketCap":117864983},{"date":"2022-01-28","current":-4.978452,"twenty":-6.290091,"median":-2.928404,"eighty":-1.751724,"marketCap":115221282},{"date":"2022-02-04","current":-4.911818,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113679124},{"date":"2022-02-11","current":-4.816628,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111476040},{"date":"2022-02-18","current":-4.835666,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111916657},{"date":"2022-02-25","current":-4.807109,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":111255731},{"date":"2022-03-04","current":-4.730957,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":109493264},{"date":"2022-03-11","current":-4.569133,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":105748022},{"date":"2022-03-18","current":-4.845185,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112136965},{"date":"2022-03-25","current":-4.549642,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":112712827},{"date":"2022-04-01","current":-4.585395,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":113598586},{"date":"2022-04-08","current":-4.647964,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":115148664},{"date":"2022-04-14","current":-6.078107,"twenty":-6.290091,"median":-2.936392,"eighty":-1.751724,"marketCap":150579023},{"date":"2022-04-22","current":-6.131737,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":151907661},{"date":"2022-04-29","current":-5.345159,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":132420964},{"date":"2022-05-06","current":-5.112761,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":126663531},{"date":"2022-05-13","current":-5.563231,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":136760909},{"date":"2022-05-20","current":-5.853487,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":143896261},{"date":"2022-05-27","current":-5.447129,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":133906768},{"date":"2022-06-03","current":-5.185899,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":127484952},{"date":"2022-06-10","current":-4.914994,"twenty":-6.296594,"median":-2.936392,"eighty":-1.751724,"marketCap":120825290},{"date":"2022-06-17","current":-4.992395,"twenty":-6.296594,"median":-2.939684,"eighty":-1.751724,"marketCap":122728050},{"date":"2022-06-24","current":-4.944019,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":121538825},{"date":"2022-07-01","current":-4.798891,"twenty":-6.297837,"median":-2.93857,"eighty":-1.7516,"marketCap":117971149},{"date":"2022-07-08","current":-5.050446,"twenty":-6.297837,"median":-2.941386,"eighty":-1.7516,"marketCap":124155121},{"date":"2022-07-15","current":-4.885968,"twenty":-6.297837,"median":-2.957708,"eighty":-1.7516,"marketCap":120111755},{"date":"2022-07-22","current":-4.682789,"twenty":-6.297837,"median":-2.982798,"eighty":-1.7516,"marketCap":115117009},{"date":"2022-07-29","current":-4.769866,"twenty":-6.297837,"median":-3.02078,"eighty":-1.7516,"marketCap":117257614},{"date":"2022-08-05","current":-5.543881,"twenty":-6.297837,"median":-3.040268,"eighty":-1.7516,"marketCap":136285219},{"date":"2022-08-12","current":-5.446277,"twenty":-6.297837,"median":-3.06668,"eighty":-1.7516,"marketCap":148841305},{"date":"2022-08-19","current":-5.418631,"twenty":-6.297837,"median":-3.084118,"eighty":-1.7516,"marketCap":148085765},{"date":"2022-08-26","current":-6.146644,"twenty":-6.297837,"median":-3.118224,"eighty":-1.7516,"marketCap":167981642},{"date":"2022-09-02","current":-7.335426,"twenty":-6.309848,"median":-3.142585,"eighty":-1.7516,"marketCap":200469845},{"date":"2022-09-09","current":-7.814624,"twenty":-6.317251,"median":-3.162074,"eighty":-1.7516,"marketCap":213565865},{"date":"2022-09-16","current":-7.353856,"twenty":-6.347186,"median":-3.184394,"eighty":-1.7516,"marketCap":200973538},{"date":"2022-09-23","current":-6.727212,"twenty":-6.375565,"median":-3.188508,"eighty":-1.7516,"marketCap":183847974},{"date":"2022-09-30","current":-6.800935,"twenty":-6.426974,"median":-3.264391,"eighty":-1.7516,"marketCap":185862746},{"date":"2022-10-07","current":-7.095826,"twenty":-6.466892,"median":-3.372124,"eighty":-1.7516,"marketCap":193921835},{"date":"2022-10-14","current":-6.81015,"twenty":-6.493464,"median":-3.432024,"eighty":-1.7516,"marketCap":186114593},{"date":"2022-10-21","current":-6.644274,"twenty":-6.514823,"median":-3.497692,"eighty":-1.7516,"marketCap":181581355},{"date":"2022-10-28","current":-8.966544,"twenty":-6.528686,"median":-3.556724,"eighty":-1.7516,"marketCap":245046683},{"date":"2022-11-04","current":-10.044741,"twenty":-6.545571,"median":-3.607395,"eighty":-1.7516,"marketCap":274512728},{"date":"2022-11-11","current":-10.9202,"twenty":-6.573735,"median":-3.676581,"eighty":-1.7516,"marketCap":298438149},{"date":"2022-11-18","current":-10.007105,"twenty":-6.621418,"median":-3.751613,"eighty":-1.7516,"marketCap":304015840},{"date":"2022-11-25","current":-9.227003,"twenty":-6.631226,"median":-3.851007,"eighty":-1.7516,"marketCap":280316366},{"date":"2022-12-02","current":-9.453484,"twenty":-6.646579,"median":-4.155392,"eighty":-1.7516,"marketCap":287196858},{"date":"2022-12-09","current":-9.034075,"twenty":-6.660035,"median":-4.496012,"eighty":-1.7516,"marketCap":274455205},{"date":"2022-12-16","current":-9.302497,"twenty":-6.679082,"median":-4.567519,"eighty":-1.7516,"marketCap":282609863},{"date":"2022-12-23","current":-8.421738,"twenty":-6.724542,"median":-4.587809,"eighty":-1.7516,"marketCap":255852392},{"date":"2022-12-30","current":-8.933417,"twenty":-6.753947,"median":-4.634413,"eighty":-1.7516,"marketCap":271397208},{"date":"2023-01-06","current":-8.287527,"twenty":-6.778375,"median":-4.653764,"eighty":-1.7516,"marketCap":251775063},{"date":"2023-01-13","current":-8.514008,"twenty":-6.80712,"median":-4.692464,"eighty":-1.7516,"marketCap":258655555},{"date":"2023-01-20","current":-9.227003,"twenty":-6.81015,"median":-4.72841,"eighty":-1.7516,"marketCap":280316366},{"date":"2023-01-27","current":-9.696742,"twenty":-6.841186,"median":-4.769866,"eighty":-1.7516,"marketCap":294587017},{"date":"2023-02-03","current":-10.241974,"twenty":-6.890177,"median":-4.79759,"eighty":-1.7516,"marketCap":311151166},{"date":"2023-02-10","current":-10.90464,"twenty":-6.916268,"median":-4.808567,"eighty":-1.755491,"marketCap":331282978},{"date":"2023-02-17","current":-11.542143,"twenty":-6.965611,"median":-4.818242,"eighty":-1.762031,"marketCap":350650290},{"date":"2023-02-24","current":-7.767459,"twenty":-7.019706,"median":-4.835666,"eighty":-1.778348,"marketCap":235975413},{"date":"2023-03-03","current":-8.497231,"twenty":-7.046348,"median":-4.884816,"eighty":-1.798523,"marketCap":258145889},{"date":"2023-03-10","current":-7.138345,"twenty":-7.08043,"median":-4.911818,"eighty":-1.80875,"marketCap":216862934},{"date":"2023-03-17","current":-7.784236,"twenty":-7.114972,"median":-4.933993,"eighty":-1.831633,"marketCap":236485079},{"date":"2023-03-24","current":-7.834565,"twenty":-7.149721,"median":-4.949894,"eighty":-1.842907,"marketCap":238014078},{"date":"2023-03-31","current":-7.926835,"twenty":-7.207328,"median":-4.990183,"eighty":-1.866152,"marketCap":240817241},{"date":"2023-04-06","current":-7.306109,"twenty":-7.239688,"median":-5.004539,"eighty":-1.891427,"marketCap":221959595},{"date":"2023-04-14","current":-7.691966,"twenty":-7.254508,"median":-5.040771,"eighty":-1.905611,"marketCap":233681916},{"date":"2023-04-21","current":-6.93556,"twenty":-7.254508,"median":-5.064123,"eighty":-1.925645,"marketCap":228991393},{"date":"2023-04-28","current":-6.834254,"twenty":-7.259978,"median":-5.09268,"eighty":-1.966075,"marketCap":225646574},{"date":"2023-05-05","current":-6.912182,"twenty":-7.259978,"median":-5.127848,"eighty":-1.993151,"marketCap":228219511},{"date":"2023-05-12","current":-6.452409,"twenty":-7.259978,"median":-5.159313,"eighty":-2.00625,"marketCap":213039183},{"date":"2023-05-19","current":-5.532558,"twenty":-7.259978,"median":-5.225075,"eighty":-2.02033,"marketCap":215354826},{"date":"2023-05-26","current":-5.597458,"twenty":-7.259978,"median":-5.238371,"eighty":-2.043298,"marketCap":217881064},{"date":"2023-06-02","current":-5.658521,"twenty":-7.261956,"median":-5.25221,"eighty":-2.054966,"marketCap":220257948},{"date":"2023-06-09","current":-5.88242,"twenty":-7.263934,"median":-5.28259,"eighty":-2.061028,"marketCap":228973191},{"date":"2023-06-16","current":-5.251434,"twenty":-7.263934,"median":-5.321351,"eighty":-2.082067,"marketCap":204412053},{"date":"2023-06-23","current":-5.475332,"twenty":-7.265912,"median":-5.34293,"eighty":-2.081273,"marketCap":213127295},{"date":"2023-06-30","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-07","current":-4.966472,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":193319926},{"date":"2023-07-14","current":-4.851131,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":188830255},{"date":"2023-07-21","current":-4.891839,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":190414845},{"date":"2023-07-28","current":-4.688295,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":182491897},{"date":"2023-08-04","current":-4.661156,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":181435504},{"date":"2023-08-11","current":-4.464397,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173776655},{"date":"2023-08-18","current":-3.583054,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166035160},{"date":"2023-08-25","current":-3.484011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":161445570},{"date":"2023-09-01","current":-3.501489,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":162255497},{"date":"2023-09-08","current":-3.752011,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":173864460},{"date":"2023-09-15","current":-3.87436,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":179533953},{"date":"2023-09-22","current":-3.66462,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":169814822},{"date":"2023-09-29","current":-3.588881,"twenty":-7.265912,"median":-5.345159,"eighty":-2.079954,"marketCap":166305135},{"date":"2023-10-06","current":-3.542272,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":164145328},{"date":"2023-10-13","current":-3.460706,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":160365666},{"date":"2023-10-20","current":-3.355836,"twenty":-7.265912,"median":-5.351594,"eighty":-2.078635,"marketCap":155506101},{"date":"2023-10-27","current":-3.227662,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":149566631},{"date":"2023-11-03","current":-2.466025,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":123648948},{"date":"2023-11-10","current":-2.553215,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":128020769},{"date":"2023-11-17","current":-2.482141,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":124457022},{"date":"2023-11-24","current":-2.438403,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":122263946},{"date":"2023-12-01","current":-2.50401,"twenty":-7.265912,"median":-5.358029,"eighty":-2.074677,"marketCap":125553559},{"date":"2023-12-08","current":-2.897653,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":145291237},{"date":"2023-12-15","current":-2.782841,"twenty":-7.265912,"median":-5.358029,"eighty":-2.075996,"marketCap":139534414},{"date":"2023-12-22","current":-2.618823,"twenty":-7.265912,"median":-5.358029,"eighty":-2.097526,"marketCap":131310382},{"date":"2023-12-29","current":-2.733635,"twenty":-7.265912,"median":-5.358029,"eighty":-2.124592,"marketCap":137067205},{"date":"2024-01-05","current":-2.853915,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143098162},{"date":"2024-01-12","current":-2.826579,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":141727489},{"date":"2024-01-19","current":-2.733635,"twenty":-7.267091,"median":-5.358029,"eighty":-2.138602,"marketCap":137067205},{"date":"2024-01-26","current":-2.86485,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":143646430},{"date":"2024-02-02","current":-3.039802,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":152418731},{"date":"2024-02-09","current":-2.851674,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":142985799},{"date":"2024-02-16","current":-3.255892,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":163253690},{"date":"2024-02-23","current":-3.732094,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":187130930},{"date":"2024-03-01","current":-4.723259,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":236828907},{"date":"2024-03-08","current":-4.213833,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":211285813},{"date":"2024-03-15","current":-3.471844,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":174081740},{"date":"2024-03-22","current":-5.044418,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":252932162},{"date":"2024-03-28","current":-4.396562,"twenty":-7.265912,"median":-5.358029,"eighty":-2.147942,"marketCap":220448010},{"date":"2024-04-05","current":-5.497751,"twenty":-7.266502,"median":-5.358029,"eighty":-2.143272,"marketCap":268389232},{"date":"2024-04-12","current":-5.473665,"twenty":-7.266502,"median":-5.381721,"eighty":-2.143272,"marketCap":267213375},{"date":"2024-04-19","current":-4.01643,"twenty":-7.266502,"median":-5.384329,"eighty":-2.165076,"marketCap":196074061},{"date":"2024-04-26","current":-3.950192,"twenty":-7.265912,"median":-5.38404,"eighty":-2.285319,"marketCap":192840456},{"date":"2024-05-03","current":-5.610325,"twenty":-7.265912,"median":-5.384619,"eighty":-2.317135,"marketCap":260605196},{"date":"2024-05-10","current":-5.706502,"twenty":-7.265912,"median":-5.393914,"eighty":-2.369797,"marketCap":265072713},{"date":"2024-05-17","current":-6.315623,"twenty":-7.265912,"median":-5.409317,"eighty":-2.438403,"marketCap":293366992},{"date":"2024-05-24","current":-5.398735,"twenty":-7.265912,"median":-5.418631,"eighty":-2.471635,"marketCap":250776657},{"date":"2024-05-31","current":-5.19997,"twenty":-7.265912,"median":-5.41947,"eighty":-2.487608,"marketCap":241543787},{"date":"2024-06-07","current":-5.123028,"twenty":-7.265912,"median":-5.424506,"eighty":-2.50401,"marketCap":237969773},{"date":"2024-06-14","current":-5.142263,"twenty":-7.266502,"median":-5.425176,"eighty":-2.545152,"marketCap":238863277},{"date":"2024-06-21","current":-4.840909,"twenty":-7.267091,"median":-5.425846,"eighty":-2.609077,"marketCap":224865055},{"date":"2024-06-28","current":-4.73832,"twenty":-7.26886,"median":-5.446277,"eighty":-2.646159,"marketCap":220099702},{"date":"2024-07-05","current":-4.66779,"twenty":-7.26886,"median":-5.446277,"eighty":-2.721782,"marketCap":216823523},{"date":"2024-07-12","current":-4.731908,"twenty":-7.26886,"median":-5.446277,"eighty":-2.760972,"marketCap":219801868},{"date":"2024-07-15","current":-4.776791,"twenty":-7.26886,"median":-5.446277,"eighty":-2.766106,"marketCap":221886709},{"date":"2024-08-02","current":-4.244611,"twenty":-7.27988,"median":-5.464392,"eighty":-2.838607,"marketCap":197166445},{"date":"2024-08-09","current":-1.761538,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":75082046},{"date":"2024-08-16","current":-1.425311,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":60751033},{"date":"2024-08-23","current":-1.491095,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":63554927},{"date":"2024-08-30","current":-1.396074,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":59504858},{"date":"2024-09-06","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-09-13","current":-1.43262,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":61062576},{"date":"2024-09-20","current":-1.374146,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":58570226},{"date":"2024-09-27","current":-1.308362,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55766333},{"date":"2024-10-04","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-10-11","current":-1.191414,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":50781632},{"date":"2024-10-18","current":-1.257197,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":53585526},{"date":"2024-10-25","current":-1.22796,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":52339351},{"date":"2024-10-31","current":-1.301053,"twenty":-7.27988,"median":-5.464392,"eighty":-2.849738,"marketCap":55454789},{"date":"2024-11-08","current":-1.3376,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":57012508},{"date":"2024-11-15","current":-1.258053,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":51473220},{"date":"2024-11-22","current":-1.12081,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":45857959},{"date":"2024-11-29","current":-1.097937,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":44922083},{"date":"2024-12-06","current":-0.930196,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38058987},{"date":"2024-12-13","current":-0.95307,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":38994863},{"date":"2024-12-20","current":-0.853951,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":34939397},{"date":"2024-12-27","current":-0.983568,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":40242699},{"date":"2025-01-03","current":-0.960695,"twenty":-7.282868,"median":-5.464392,"eighty":-2.852013,"marketCap":39306822},{"date":"2025-01-10","current":-0.998817,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":40866617},{"date":"2025-01-17","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-01-24","current":-1.021691,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":41802493},{"date":"2025-01-31","current":-0.930196,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38058987},{"date":"2025-02-07","current":-0.876824,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-02-14","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-02-21","current":-0.937821,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38370945},{"date":"2025-02-28","current":-0.838702,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":34315480},{"date":"2025-03-07","current":-0.8692,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":35563315},{"date":"2025-03-14","current":-0.914947,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":37435069},{"date":"2025-03-21","current":-1.075063,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43986206},{"date":"2025-03-28","current":-1.441042,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":58960233},{"date":"2025-04-04","current":-1.133862,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":43362288},{"date":"2025-04-11","current":-0.938087,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":35875274},{"date":"2025-04-17","current":-1.01966,"twenty":-7.285855,"median":-5.464392,"eighty":-2.853369,"marketCap":38994863},{"date":"2025-04-25","current":-1.035975,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":39618781},{"date":"2025-05-02","current":-1.215435,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":46481877},{"date":"2025-05-09","current":-1.166491,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":44610124},{"date":"2025-05-16","current":-1.048751,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":47729713},{"date":"2025-05-23","current":-1.165279,"twenty":-7.286554,"median":-5.465435,"eighty":-2.853806,"marketCap":53033014},{"date":"2025-05-30","current":-1.083024,"twenty":-7.286554,"median":-5.465435,"eighty":-2.851029,"marketCap":49289507},{"date":"2025-06-06","current":-1.158424,"twenty":-7.286554,"median":-5.465435,"eighty":-2.826061,"marketCap":52721055},{"date":"2025-06-13","current":-1.089879,"twenty":-7.286554,"median":-5.458627,"eighty":-2.778467,"marketCap":49601466},{"date":"2025-06-20","current":-1.000769,"twenty":-7.287253,"median":-5.446277,"eighty":-2.733635,"marketCap":45546000},{"date":"2025-06-27","current":-1.110442,"twenty":-7.267091,"median":-5.417858,"eighty":-2.646159,"marketCap":50537343},{"date":"2025-07-03","current":-0.98706,"twenty":-7.267091,"median":-5.407728,"eighty":-2.602421,"marketCap":44922083},{"date":"2025-07-11","current":-1.06246,"twenty":-7.267091,"median":-5.393914,"eighty":-2.51057,"marketCap":48353631},{"date":"2025-07-18","current":-1.110442,"twenty":-7.267091,"median":-5.384619,"eighty":-2.465911,"marketCap":50537343},{"date":"2025-07-25","current":-1.247534,"twenty":-7.249357,"median":-5.371324,"eighty":-2.389197,"marketCap":56776521},{"date":"2025-08-01","current":-1.117297,"twenty":-7.239384,"median":-5.345159,"eighty":-1.983741,"marketCap":50849302},{"date":"2025-08-08","current":-1.069315,"twenty":-7.153881,"median":-5.321351,"eighty":-1.539336,"marketCap":48665589},{"date":"2025-08-15","current":-1.254343,"twenty":-7.149721,"median":-5.271609,"eighty":-1.466243,"marketCap":51473220},{"date":"2025-08-22","current":-1.299955,"twenty":-7.149721,"median":-5.252754,"eighty":-1.437673,"marketCap":53344973},{"date":"2025-08-29","current":-1.322762,"twenty":-7.149721,"median":-5.238371,"eighty":-1.415078,"marketCap":54280850},{"date":"2025-09-05","current":-1.284751,"twenty":-7.150187,"median":-5.238371,"eighty":-1.391689,"marketCap":52721055},{"date":"2025-09-12","current":-1.277149,"twenty":-7.149721,"median":-5.234275,"eighty":-1.374146,"marketCap":52409096},{"date":"2025-09-19","current":-1.254343,"twenty":-7.149721,"median":-5.2246,"eighty":-1.364411,"marketCap":51473220},{"date":"2025-09-26","current":-1.208731,"twenty":-7.149721,"median":-5.178605,"eighty":-1.342132,"marketCap":49601466},{"date":"2025-10-03","current":-1.216333,"twenty":-7.149721,"median":-5.149794,"eighty":-1.33029,"marketCap":49913425},{"date":"2025-10-10","current":-1.140312,"twenty":-7.149721,"median":-5.127848,"eighty":-1.322893,"marketCap":46793836},{"date":"2025-10-17","current":-1.109903,"twenty":-7.141548,"median":-5.111718,"eighty":-1.315672,"marketCap":45546000},{"date":"2025-10-24","current":-1.087097,"twenty":-7.122322,"median":-5.09268,"eighty":-1.314425,"marketCap":44610124},{"date":"2025-10-31","current":-1.079495,"twenty":-7.097179,"median":-5.082259,"eighty":-1.301053,"marketCap":44298165},{"date":"2025-11-07","current":-1.003474,"twenty":-7.086864,"median":-5.050446,"eighty":-1.299955,"marketCap":41178576},{"date":"2025-11-14","current":-0.95026,"twenty":-7.053435,"median":-5.031096,"eighty":-1.284751,"marketCap":38994863},{"date":"2025-11-21","current":-1.163117,"twenty":-7.032648,"median":-5.00207,"eighty":-1.274108,"marketCap":40242699},{"date":"2025-11-28","current":-1.244265,"twenty":-6.985641,"median":-5.000396,"eighty":-1.260388,"marketCap":43050329},{"date":"2025-12-05","current":-1.30738,"twenty":-6.965611,"median":-4.98838,"eighty":-1.256074,"marketCap":45234041},{"date":"2025-12-12","current":-1.30738,"twenty":-6.926664,"median":-4.949894,"eighty":-1.256074,"marketCap":45234041},{"date":"2025-12-19","current":-1.43361,"twenty":-6.879094,"median":-4.937086,"eighty":-1.256074,"marketCap":49601466},{"date":"2025-12-26","current":-1.43361,"twenty":-6.857633,"median":-4.925763,"eighty":-1.256074,"marketCap":49601466},{"date":"2026-01-02","current":-1.226232,"twenty":-6.856789,"median":-4.912194,"eighty":-1.254389,"marketCap":42426411},{"date":"2026-01-09","current":-1.289347,"twenty":-6.856789,"median":-4.902299,"eighty":-1.254371,"marketCap":44610124},{"date":"2026-01-16","current":-1.18115,"twenty":-6.856789,"median":-4.87827,"eighty":-1.249888,"marketCap":40866617},{"date":"2026-01-23","current":-1.208199,"twenty":-6.856789,"median":-4.851131,"eighty":-1.245751,"marketCap":41802493},{"date":"2026-01-30","current":-1.109019,"twenty":-6.856789,"median":-4.844346,"eighty":-1.2396,"marketCap":38370945},{"date":"2026-02-06","current":-1.045904,"twenty":-6.856789,"median":-4.830776,"eighty":-1.233764,"marketCap":36187233},{"date":"2026-02-13","current":-1.000822,"twenty":-6.856789,"median":-4.816628,"eighty":-1.22796,"marketCap":34627439},{"date":"2026-02-18","current":-0.973773,"twenty":-6.856789,"median":-4.808567,"eighty":-1.227564,"marketCap":33691562}],"updateTime":1771526064238},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATNM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612454217","title":"Actinium Pharmaceuticals to Present ATNM-400 and Actimab-A Data at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2612454217","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612454217?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:43","pubTimestamp":1771332201,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. announced that it will present two abstracts at the American Association for Cancer Research  Annual Meeting 2026, scheduled for April 17-22, 2026, in San Diego, California. The presentations will feature updates on the ATNM-400 and Actimab-A programs across solid tumors and hematologic oncology applications. Details of the research will be disclosed at the conference in accordance with AACR guidelines.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL1fH7bP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2611195043","title":"Actinium Pharmaceuticals Inc - Steve O'loughlin Resigns as CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195043","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195043?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:11","pubTimestamp":1771020692,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2611282195","title":"Actinium Pharmaceuticals CEO Sandesh Seth Named Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2611282195","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611282195?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:01","pubTimestamp":1771020087,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. announced that Steve O'Loughlin will resign as Chief Financial Officer effective February 27, 2026. Sandesh Seth, the company's current Chairman and Chief Executive Officer, has been appointed to also serve as the principal financial officer following O'Loughlin's departure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL3D95WM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2590150176","title":"Actinium Pharmaceuticals Unveils Potent Preclinical Results for ATNM-400 Targeted Radiotherapy in Breast Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2590150176","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590150176?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:45","pubTimestamp":1765547137,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. announced the presentation of new preclinical data for ATNM-400, its Actinium-225 based antibody radioconjugate, at the 2025 San Antonio Breast Cancer Symposium . The data demonstrated robust anti-tumor activity and a favorable tolerability profile across various preclinical breast cancer models, including hormone receptor-positive, triple-negative, and tamoxifen- and trastuzumab-resistant tumors. ATNM-400 targets a validated cancer antigen overexpressed in breast cancer and other solid tumors such as prostate cancer and non-small cell lung cancer. The company indicated plans to advance the development of ATNM-400 toward clinical readiness. The results were presented at the 2025 SABCS.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLb2QnkG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2588780267","title":"BRIEF-ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCS","url":"https://stock-news.laohu8.com/highlight/detail?id=2588780267","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588780267?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:52","pubTimestamp":1764597175,"startTime":"0","endTime":"0","summary":"BRIEF-ctinium’s Atnm-400 Shows Strong Efficacy in TNBC, Beats Therapy Resistance at SABCSDec 1 (Reuters) - Actinium Pharmaceuticals Inc ATNM.A:ACTINIUM PHARMACEUTICALS ANNOUNCES ATNM-400 DATA DEMONSTR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA4HB0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2588778209","title":"Actinium Pharmaceuticals Unveils Preclinical Data Showing ATNM-400 Overcomes Breast Cancer Therapy Resistance","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778209?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:45","pubTimestamp":1764596742,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. has announced new preclinical data for ATNM-400, a first-in-class Actinium-225 antibody radioconjugate, demonstrating significant anti-tumor activity in hormone receptor positive (HR+), HER2 positive , and triple-negative breast cancer  models resistant to standard-of-care therapies, including tamoxifen and trastuzumab. The data indicate that ATNM-400 may overcome resistance to both endocrine and HER2-targeted therapies and shows potent tumor growth inhibition in TNBC models. These results are scheduled to be presented at the San Antonio Breast Cancer Symposium on December 11, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4nNLjM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2588778400","title":"Actinium Pharmaceuticals Announces Atnm-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and Her2-Targeted Therapy Resistance Being Presented at the San Antonio Breast Cancer Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2588778400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588778400?lang=en_us&edition=fundamental","pubTime":"2025-12-01 21:45","pubTimestamp":1764596700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA4HB0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2586305295","title":"Actinium Pharmaceuticals Holds Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586305295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586305295?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:31","pubTimestamp":1764196284,"startTime":"0","endTime":"0","summary":"An update from Actinium Pharmaceuticals ( ($ATNM) ) is now available. On November 26, 2025, Actinium Pharmaceuticals held its annual meeting of sto...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinium-pharmaceuticals-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinium-pharmaceuticals-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2586293358","title":"Actinium Pharmaceuticals Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586293358","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586293358?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:01","pubTimestamp":1764194488,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. held its annual meeting of stockholders on November 26, 2025. At the meeting, Ajit S. Shetty and June S. Almenoff were elected to the board of directors. Stockholders also approved the ratification of CBIZ as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025. All proposals presented at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL7F2kc9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2584337929","title":"Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies and Strong Financial Position Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2584337929","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584337929?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:45","pubTimestamp":1763570732,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Actinium Pharmaceuticals and keeping the price target at $5.00. Jason McCarthy’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-developments-in-targeted-radiotherapies-and-strong-financial-position-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-developments-in-targeted-radiotherapies-and-strong-financial-position-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2581088313","title":"Actinium Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581088313","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581088313?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:03","pubTimestamp":1762380230,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. has announced that it will hold its Annual Meeting of Stockholders on November 26, 2025, at The Garden City Hotel in Garden City, New York. The meeting will address business matters as described in the proxy statement and will provide an opportunity for stockholders to review the company's performance and vote on relevant proposals. The Notice of Annual Meeting, proxy statement, and 2024 Annual Report are available for review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL8ZjfSd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2581777386","title":"Actinium Pharmaceuticals: Promising Developments in Targeted Radiotherapies Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777386","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581777386?lang=en_us&edition=fundamental","pubTime":"2025-11-06 00:55","pubTimestamp":1762361746,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy of Maxim Group maintained a Buy rating on Actinium Pharmaceuticals, retaining the price target of $5.00. Jason McCarthy has ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-developments-in-targeted-radiotherapies-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-developments-in-targeted-radiotherapies-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2580736006","title":"Actinium Pharmaceuticals Unveils Promising ATNM-400 Data for Drug-Resistant Breast Cancer at SABCS 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580736006","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580736006?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:30","pubTimestamp":1762259453,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. announced that new preclinical data for its lead antibody radioconjugate program, ATNM-400, will be presented at the 2025 San Antonio Breast Cancer Symposium , scheduled for December 10-14, 2025. The data, to be presented in poster session 4 on December 11, will highlight the anti-tumor activity of ATNM-400 in tamoxifen- and trastuzumab-resistant breast cancer models. According to the company, preclinical results demonstrate efficacy of ATNM-400 as a monotherapy and in combination with standard-of-care therapies across breast cancer, prostate cancer, and non-small cell lung cancer models. The company states that these findings support further development of ATNM-400 in solid tumors, particularly in patient populations with resistance to current hormone and HER2-targeted therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-ge","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL30cyKb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2580215785","title":"Actinium Pharmaceuticals to Join Stephens Biotechnology Virtual Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215785?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:32","pubTimestamp":1762176727,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. will participate in the Stephens Biotechnology Virtual Fireside Chat on November 4, 2025. Chairman and CEO Sandesh Seth will join the event, and the management team will be available for one-on-one meetings with investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Actinium Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on November 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL3sq0kZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2579619839","title":"Actinium Pharmaceuticals: Promising Preclinical Success and Innovative Radiotherapy Developments Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2579619839","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579619839?lang=en_us&edition=fundamental","pubTime":"2025-10-28 23:55","pubTimestamp":1761666912,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-preclinical-success-and-innovative-radiotherapy-developments-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/actinium-pharmaceuticals-promising-preclinical-success-and-innovative-radiotherapy-developments-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2578648300","title":"Actinium Pharmaceuticals’ ATNM-400 shows superior anti-tumor activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2578648300","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578648300?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:15","pubTimestamp":1761563751,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals (ATNM) announced the presentation of the first ever preclinical data of ATNM-400 in non-small cell lung cancer, or NSCLC. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-atnm-400-shows-superior-anti-tumor-activity-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/actinium-pharmaceuticals-atnm-400-shows-superior-anti-tumor-activity-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM","BK4139"],"gpt_icon":0},{"id":"2577516661","title":"Actinium Pharmaceuticals Reports Potent Preclinical Efficacy for Novel ATNM-400 Radiotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2577516661","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577516661?lang=en_us&edition=fundamental","pubTime":"2025-10-24 20:30","pubTimestamp":1761309024,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Inc. has announced new preclinical research results for ATNM-400, a first-in-class antibody radioconjugate armed with Actinium-225 , at the 32nd Annual Prostate Cancer Foundation Scientific Retreat, held October 23-25, 2025. The data demonstrated that ATNM-400, which targets a novel, non-PSMA antigen, showed superior efficacy and prolonged survival compared to existing PSMA-targeted radioligand therapies in models of low-PSMA and treatment-resistant prostate cancer. Notably, ATNM-400 remained effective even after androgen receptor pathway inhibitor  therapy and 177Lu-PSMA-617 therapy. The combination of ATNM-400 with the ARPI enzalutamide achieved complete tumor regression in 40% of treated animals, highlighting promising synergy. Additionally, Actinium is advancing ATNM-400 into non-small cell lung cancer , where it has shown the ability to overcome resistance to EGFR-TKI therapy in preclinical models.Disclaimer: This news brief was created by Public Technolog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL7ZG59S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2575035739","title":"Promising Pipeline and Strategic Developments Drive Buy Rating for Actinium Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2575035739","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575035739?lang=en_us&edition=fundamental","pubTime":"2025-10-15 23:15","pubTimestamp":1760541324,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Actinium Pharmaceuticals and keeping the price target at $5.00. Jason McCarthy h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-developments-drive-buy-rating-for-actinium-pharmaceuticals-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-pipeline-and-strategic-developments-drive-buy-rating-for-actinium-pharmaceuticals-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATNM"],"gpt_icon":0},{"id":"2575855662","title":"Actinium Pharmaceuticals Unveils Preclinical Data Showing ATNM-400 Overcomes Osimertinib Resistance in EGFR-Mutated NSCLC at AACR-NCI-EORTC Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2575855662","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575855662?lang=en_us&edition=fundamental","pubTime":"2025-10-14 00:11","pubTimestamp":1760371868,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Unveils Preclinical Data Showing ATNM-400 Overcomes Osimertinib Resistance in EGFR-Mutated NSCLC at AACR-NCI-EORTC Conference. Actinium Pharmaceuticals Inc. announced that the first preclinical data from its ATNM-400 program in non-small cell lung cancer  has been accepted for presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, scheduled for October 22-26, 2025. ATNM-400 is a first-in-class Actinium-225 antibody radioconjugate with demonstrated preclinical activity in both prostate cancer and NSCLC. The new findings indicate that ATNM-400 can overcome resistance to the EGFR inhibitor osimertinib in EGFR-mutated NSCLC, addressing a significant unmet clinical need. The results will be presented during Poster Session C on October 25, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDL66WzFx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATNM"],"gpt_icon":0},{"id":"2575279406","title":"Actinium Pharmaceuticals Unveils Promising Preclinical Data for ATNM-400, Highlighting Durable Tumor Control in Resistant Prostate Cancer Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2575279406","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575279406?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:31","pubTimestamp":1760358709,"startTime":"0","endTime":"0","summary":"Actinium Pharmaceuticals Unveils Promising Preclinical Data for ATNM-400, Highlighting Durable Tumor Control in Resistant Prostate Cancer Models. Actinium Pharmaceuticals Inc. has announced that preclinical data for its novel antibody radioconjugate, ATNM-400, will be presented at the 32nd Annual Prostate Cancer Foundation Scientific Retreat, scheduled for October 23-25, 2025, in Carlsbad, California. ATNM-400 is a first-in-class therapy armed with the alpha-emitter Actinium-225 and targets a non-PSMA antigen associated with prostate cancer progression. Preclinical studies have shown that ATNM-400 induces durable anti-tumor activity in metastatic castration-resistant prostate cancer models, including those resistant to standard-of-care therapies such as enzalutamide and 177Lu-PSMA-617. The company reports that ATNM-400 demonstrated efficacy independent of PSMA expression levels and outperformed current therapies in preclinical models. The results will be made available online following","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDL53R4yG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATNM","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}